Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05595629 · ClinicalTrials.gov registry record · NA
App-based Remote Blood Pressure Monitoring
A NA study of Preeclampsia and Gestational Hypertension, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05595629: Completed NA study of Preeclampsia and Gestational Hypertension, sponsored by Women and Infants Hospital of Rhode Island.
NCT05595629 is a NA study of Preeclampsia and Gestational Hypertension that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 120 participants, below the 1,124-participant average among 48 other Preeclampsia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05595629, a NA study of Preeclampsia and Gestational Hypertension, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to each individual text message. A bluetooth-enabled blood pressure cuff that synchs automatically a smartphone application that leverages Artificial Intelligence to provide tailored recommendations based on recorded blood pressure measurements--and can also provide on-demand education on hypertension--may be less costly way to provide similar support.
Primary Outcome
Number of participants who adhere to recommended blood pressure check after hospital discharge
Conditions Studied
Interventions
- BEHAVIORAL App-based remote blood pressure monitoring
- BEHAVIORAL text-message based remote blood pressure monitoring
Study Locations (1)
Rhode Island
- Women & Infants Hospital of Rhode Island - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-08-30 |
| Phase | NA |
What the finished NCT05595629 record still lists
NCT05595629 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,124-participant average among 48 other Preeclampsia trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which App-based remote blood pressure monitoring is the first listed.
NCT05595629 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05595629 about?
NCT05595629 is a clinical study titled "App-based Remote Blood Pressure Monitoring". Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to ...
What is the current status of trial NCT05595629?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2022-11-07. Estimated completion is 2023-08-30.
What conditions does trial NCT05595629 study?
This clinical trial studies the following conditions: Preeclampsia, Gestational Hypertension, Chronic Hypertension Complicating Pregnancy.
What interventions are being tested in trial NCT05595629?
The interventions under investigation include: App-based remote blood pressure monitoring (BEHAVIORAL), text-message based remote blood pressure monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT05595629?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05595629 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05595629's enrollment target sits among peer trials
120 29th of 48 higher than 19 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI